These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14751333)

  • 1. Considering schizophrenia from a prevention perspective.
    Compton MT
    Am J Prev Med; 2004 Feb; 26(2):178-85. PubMed ID: 14751333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing clinical deterioration in the course of schizophrenia: the potential for neuroprotection.
    Lieberman JA; Malaspina D; Jarskog LF
    CNS Spectr; 2006 Apr; 11(4):suppl 1-13; quiz suppl 14-5. PubMed ID: 16641837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evidence for an association between minor physical anomalies and second trimester neurodevelopment in schizophrenia.
    Green MF; Bracha HS; Satz P; Christenson CD
    Psychiatry Res; 1994 Aug; 53(2):119-27. PubMed ID: 7824672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome.
    Gothelf D; Frisch A; Munitz H; Rockah R; Laufer N; Mozes T; Hermesh H; Weizman A; Frydman M
    Schizophr Res; 1999 Jan; 35(2):105-12. PubMed ID: 9988847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of schizophrenia--a review.
    Mäki P; Veijola J; Jones PB; Murray GK; Koponen H; Tienari P; Miettunen J; Tanskanen P; Wahlberg KE; Koskinen J; Lauronen E; Isohanni M
    Br Med Bull; 2005; 73-74():1-15. PubMed ID: 15947217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing schizophrenia and psychotic behaviour: definitions and methodological issues.
    Faraone SV; Brown CH; Glatt SJ; Tsuang MT
    Can J Psychiatry; 2002 Aug; 47(6):527-37. PubMed ID: 12211880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical Approach to Prevention of Schizophrenia - Concepts and Challenges.
    Radic K; Curkovic M; Bagaric D; Vilibic M; Tomic A; Zivkovic M
    Psychiatr Danub; 2018 Mar; 30(1):35-40. PubMed ID: 29546856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ethics of research into schizophrenia prevention: a carer's perspective.
    Peterson DR
    Aust N Z J Psychiatry; 2000 Nov; 34 Suppl():S201-3. PubMed ID: 11129309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precursors and prodromata of schizophrenia: findings from the Edinburgh High Risk Study and their literature context.
    Owens DG; Johnstone EC
    Psychol Med; 2006 Nov; 36(11):1501-14. PubMed ID: 16817986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of schizophrenia.
    Tsuang MT; Stone WS; Auster TL
    Expert Rev Neurother; 2010 Jul; 10(7):1165-74. PubMed ID: 20586696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preventive treatments in schizophrenia].
    Laffy-Beaufils B
    Encephale; 2006 Oct; 32(5 Pt 4):S918-20; discussion S921-2. PubMed ID: 17119507
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pre-psychotic states--contemporary diagnostic and therapeutic issues. Part II. The biological markers of the risk of schizophrenia. Therapy of pre-psychotic states].
    Szulc A; Czernikiewicz A
    Psychiatr Pol; 2007; 41(1):17-27. PubMed ID: 17494411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding predisposition to schizophrenia: toward intervention and prevention.
    Tsuang MT; Stone WS; Faraone SV
    Can J Psychiatry; 2002 Aug; 47(6):518-26. PubMed ID: 12211879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early recognition and early treatment of schizophrenia: chance or dilemma?].
    Resch F
    Z Kinder Jugendpsychiatr Psychother; 2008 Jul; 36(4):235-44. PubMed ID: 18654955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic markers as risk factors in schizophrenia: neurocognitive functions.
    Michie PT; Kent A; Stienstra R; Castine R; Johnston J; Dedman K; Wichmann H; Box J; Rock D; Rutherford E; Jablensky A
    Aust N Z J Psychiatry; 2000 Nov; 34 Suppl():S74-85. PubMed ID: 11129319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Schizophrenia and/or bipolar disorder: the neurocognitive endophenotypes].
    Kaladjian A; Azorin JM; Pomietto P; Corréard N; Belzeaux R; Adida M
    Encephale; 2012 Dec; 38 Suppl 3():S81-4. PubMed ID: 23279993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preventing violence in schizophrenia with cognitive remediation].
    Darmedru C; Demily C; Franck N
    Encephale; 2018 Apr; 44(2):158-167. PubMed ID: 28641817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advocacy for the establishment of a comprehensive strategy to reduce the "burden" of schizophrenic disorders].
    Leguay D
    Encephale; 2016 Oct; 42(5):476-483. PubMed ID: 27623121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of schizophrenia: signposts to prevention.
    McGorry PD
    Aust N Z J Psychiatry; 2000 Nov; 34 Suppl():S14-21. PubMed ID: 11129299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should we ignore dimensional risk factors in prevention of schizophrenia? Signposts to prevention.
    McConaghy N
    Aust N Z J Psychiatry; 2000 Nov; 34 Suppl():S22-5. PubMed ID: 11129312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.